Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 31.03.2025
Trident Texofab Ltd. Press Release May 29 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Trident Texofab
- Announcement under Regulation 30 (LODR)-Conversion of Securities
- Appointment Of Internal Auditor
- Result-Financial Result For The Quarter And Year Ended On March 31, 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On May 29, 2025
- Trident Texofab Ltd. Press Release May 26 2025
Later from Trident Texofab
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Trident Texofab Ltd. Press Release May 30 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement under Regulation 30 (LODR)-Investor Presentation
- Trident Texofab Ltd. Press Release May 31 2025
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab